Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
May 2017 onwards
Submit An Event
Events - October 2012
Indian Lab Automation 2012
30 Oct 2012 - 31 Oct 2012 - Mumbai, India
This conference will amalgamate the cutting-edge techniques used by leading research institutes. With access to all three tracks, Drug Discovery & Development, Advances in Genomics & Informatics and Advances in Bioanalysis, this conference aims to provide delegates with a comprehensive overview of the essential techniques required to investigate current scientific advancements.
The Flow Chemistry workshop will be taking place prior to this conference.
Drug Discovery & Development
In the ever-expanding field of drug development it is vital for scientists to remain at the forefront of drug discovery and refinement in order to keep up with consumerist demand. With a need for improved specificity and fewer side-effects in patients, our speakers will be discussing the sophisticated details of the fundamental techniques required to develop the most successful drugs.
This branch of analytical chemistry is essential in obtaining accurate quantitative measurements of drug metabolites and macromolecules. Keynote presentations will talk about innovative analytical methods, explain their movement towards a more reliable, rational approach of analysis, and describe the considerable impact these techniques can have on the overall success of pharmaceutical research.
Advances in Genomics and Informatics
Despite the remarkable feat of sequencing the human genome nearly ten years ago, the sheer volume of information that DNA provides us with requires continual advancements in the way we unravel and analyse the data. Our speakers will address numerous methods of analysis, particularly focusing on the exciting areas of epigenetics, miRNA and Next-Gen Sequencing.
For more information on the stimulating research involved in epigenetics, miRNA and Next-Gen Sequencing, please view the information on the Genomics Research Asia conference being held later this year.
Big Genetics in BC: The American Society for Human Genetics 2016 Meeting
Themes at this year's meeting ranged from the verification, validation, and sharing of data, to the translation of laboratory findings into actionable clinical results.
Cancer Genetics: Key to Diagnosis, Therapy
When applied judiciously, cancer genetics directs caregivers to the right drug at the right time, while sparing patients of unnecessary or harmful treatments.
Genetics Control Regenerative Properties Of Stem Cells
Researchers define how genetic factors control regenerative properties of blood-forming stem cells.
Diabetes Missing Link Discovered
Researchers from the University of Auckland have shown that beta catenin plays a vital role in the control of insulin release from the pancreas.
Study Reveals New Role for Hippo Pathway in Suppressing Cancer Immunity
Hippo pathway signaling regulates organ size by moderating cell growth, apoptosis and stem cell renewal, but dysregulation contributes to cancer development.
Gene-Editing Improves Vision in Blind Rats
Scientists developed a targeted gene-replacement technique that can modify genes in both dividing and non-dividing cells in living animals.
Gene Editing Yields Tomatoes That Ripen Weeks Earlier
Research team develop method to make tomato plants flower and ripen fruit two weeks faster than current growth rates.
Exploring the Genome of the River Blindness Parasite
Researchers have decoded the genome of the parasite that causes the skin and eye infection known as river blindness.
Unexpected Role for Epigenetic Enzymes in Cancer
Researchers use epigenetics to identify the role of an enzyme family as regulators of genetic message interpretation in yeast.
Gene Therapy Maintains Clotting Factor for Hemophilia Patients
Following a single gene therapy dose, the highest levels of an essential blood clotting factor IX were observed in hemophilia B patients.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
4,000+ scientific and medical posters
5,300+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!